Form 4: Cardinal Health Director, Patricia Hemingway Hall, Receives 1,730 Restricted Share Units

Patricia Hemingway Hall, a director at Cardinal Health, acquired 1,730 restricted share units on November 6, 2024, which will vest on November 6, 2025, or the date of the 2025 Annual Meeting of Shareholders if it occurs earlier.

Summary

• On November 6, 2024, Patricia Hemingway Hall, a director of Cardinal Health Inc. [CAH], acquired 1,730 common shares in the form of restricted share units.
• These restricted share units were granted at a price of $0.
• The restricted share units will vest on November 6, 2025, unless the 2025 Annual Meeting of Shareholders occurs before that date, in which case they will vest on the meeting date.
• Following the transaction, Ms. Hall directly owns 31,197 common shares.
• The transaction was reported on Form 4, filed with the SEC on November 7, 2024.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of a director's acquisition of restricted share units, which is a common practice in executive compensation. It doesn't inherently indicate positive or negative sentiment, but rather a standard business procedure.

Positives

• The acquisition of restricted share units by a director signals confidence in the company's future performance.

Future Outlook

The restricted share units will vest on November 6, 2025, or the date of the 2025 Annual Meeting of Shareholders if it occurs earlier, indicating a future incentive for the director.

Industry Context

Form 4 filings are routine disclosures required by the SEC to provide transparency regarding the transactions of company insiders. This filing indicates a grant of restricted share units, a common form of executive compensation.

Stakeholder Impact

• The acquisition of restricted share units by a director can align their interests with those of shareholders, as the value of the units is tied to the company's performance.

Key Dates